PURE · Pure Bioscience, Inc.
Market Cap
$11.70M
Shares
130.02M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-15 | — | |
| 10-Q | 2026-06-15 | 2026-04-30 | |
| 8-K | 2026-05-05 | 2026-04-30 | |
| 10-Q | 2026-03-17 | 2026-01-31 | |
| 8-K | 2026-03-17 | 2026-03-16 | |
| 8-K | 2026-02-20 | 2026-02-17 | |
| DEF 14A | 2025-12-30 | — | |
| 10-Q | 2025-12-15 | 2025-10-31 | |
| 8-K | 2025-12-15 | — | |
| 8-K | 2025-11-19 | 2025-11-17 | |
| 10-K | 2025-10-29 | 2025-07-31 | |
| 8-K | 2025-10-29 | — | |
| 10-Q | 2025-06-16 | 2025-04-30 | |
| 8-K | 2025-06-16 | — | |
| 10-Q | 2025-03-17 | 2025-01-31 | |
| 8-K | 2025-03-17 | — | |
| 8-K | 2025-01-28 | 2025-01-22 | |
| 10-Q | 2024-12-16 | 2024-10-31 | |
| 8-K | 2024-12-16 | — | |
| DEF 14A | 2024-12-12 | — | |
| 10-K | 2024-10-29 | 2024-07-31 | |
| 8-K | 2024-10-29 | — | |
| 8-K | 2024-09-20 | 2024-09-16 | |
| 8-K | 2024-08-09 | 2024-08-05 | |
| 10-Q | 2024-06-14 | 2024-04-30 | |
| 8-K | 2024-06-14 | — | |
| 8-K | 2024-05-07 | 2024-05-01 | |
| 8-K | 2024-03-27 | 2024-03-22 | |
| 10-Q | 2024-03-18 | 2024-01-31 | |
| 8-K | 2024-03-18 | — | |
| 8-K | 2024-02-26 | 2024-02-21 | |
| DEF 14A | 2024-01-10 | — | |
| 10-Q | 2023-12-14 | 2023-10-31 | |
| 8-K | 2023-12-14 | — | |
| 10-K | 2023-10-30 | 2023-07-31 | |
| 8-K | 2023-10-30 | — | |
| 8-K | 2023-07-10 | 2023-07-03 | |
| 8-K | 2023-06-14 | — | |
| 10-Q | 2023-06-14 | 2023-04-30 | |
| 8-K | 2023-03-21 | 2023-03-15 | |
| 10-Q | 2023-03-17 | 2023-01-31 | |
| 8-K | 2023-03-17 | — | |
| 8-K | 2023-02-10 | 2023-02-08 | |
| DEF 14A | 2022-12-23 | — | |
| 8-K | 2022-12-14 | — | |
| 10-Q | 2022-12-14 | 2022-10-31 | |
| 8-K | 2022-10-28 | — | |
| 10-K | 2022-10-28 | 2022-07-31 | |
| 8-K | 2022-07-19 | 2022-07-15 | |
| 8-K | 2022-06-14 | — |
Showing 1–50 of 77 filings